SCHEMBL6222984

SCHEMBL6222984

CC(C)NC(Oc1ccc(OCCCN)cc1Br)C(C)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CARM1 Q86X55 1/20 0.38
▸ ADRB2 P07550 2/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ICMT O60725 1/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ADRA2A P08913 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ THRA P10827 1/20 0.32
▸ THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6222183 0.82 CARM1 (0.38) CARM1ADRB2ALDH1A1KDM4E
SCHEMBL5631471 0.75 MAPT (0.53) ADRB2CYP2D6ADRB1
SCHEMBL5631468 0.75 MAPT (0.53) ADRB2CYP2D6ADRB1
SCHEMBL12667923 0.68 THRA (0.41) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL14572743 0.68 MAPT (0.43) ADRB2MEN1CYP2D6KMT2AADRA1A
SCHEMBL5630902 0.67 XDH (0.39) ALDH1A1NPC1HPGDRAB9A
SCHEMBL5630620 0.67 XDH (0.39) ALDH1A1NPC1HPGDRAB9A
SCHEMBL9621528 0.66 CYP1A2 (0.42) SMN1; SMN2ALDH1A1MEN1CYP1A2CYP2D6
SCHEMBL17175976 0.66 THRA (0.40) SMN1; SMN2MEN1CYP1A2CYP2C9CYP2C19
SCHEMBL16726537 0.65 CA2 (0.55) ALDH1A1LMNAHPGDKDM4EADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565472-A2 COMPOUNDS WITH MIXED PDE-INHIBITORY AND BETA-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE Artesian Therapeutics, Inc. (US) 2005-08-24 — — EP disclosed
WO-2004050657-A2 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE ARTESIAN THERAPEUTICS, INC. (US) 2004-06-17 — — WO disclosed
Send feedback